Name: Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb - Research Grade
SKU: PX-TA1750
Availability: InStock

SDS-PAGE for Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb

Size	100ug, 1MG
Isotype	IgG1, kappa
Brand	ProteoGenix
Product type	Primary Antibodies
Clonality	Monoclonal Antibody
Expression system	XtenCHO
Applications	Elisa, WB

Primary Antibodies ELISA WB COVID-19 antibodies COVID-19 products Therapeutic Antibodies Virology

Product name	Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb - Research Grade
Source	CAS 2578319-11-4
Species	Homo sapiens
Expression system	XtenCHO
Molecular weight	143.8kDa
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery lead time in business days	3-5 days if in stock; 3-5 weeks if production needed
Delivery Time	3-5 days if in stock; 3 week if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Aliases /Synonyms	Bebtelovimab,LY-CoV1404, LY3853113,SARS-CoV-2 Spike Protein,anti-SARS-CoV-2 Spike Protein
Reference	PX-TA1750
Note	For research use only. Not suitable for human use.
Isotype	IgG1,kappa
Clonality	Monoclonal Antibody

Datasheet Download

SDS-PAGE for Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb

Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Publication

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike, Sieglinde De Cae, Inge Van Molle, Loes van Schie, Sophie R. Shoemaker, Julie Deckers, Nincy Debeuf, Sahine Lameire, Wim Nerinckx, Kenny Roose, Daria Fijalkowska, Simon Devos, Anne-Sophie Desmet, Jackeline Cecilia Zavala Marchan, Toon Venneman, Koen Sedeyn, Marlies Ballegeer, Manon Vanheerswynghels, Caroline De Wolf, Hans Demol, Pieter Vanhaverbeke, Gholamreza Hassanzadeh Ghassabeh, Chiara Lonigro, Viki Bockstal, Manuela Rinaldi, Rana Abdelnabi, Johan Neyts, Susan Marqusee, Bart N. Lambrecht, Nico Callewaert, Han Remaut, Xavier Saelens, Bert Schepens, bioRxiv 2023.03.10.531533; doi: https://doi.org/10.1101/2023.03.10.531533
Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including XBB.1.5 and BQ.1.1, Kevin C. Entzminger, Jonathan K. Fleming, Paul D. Entzminger, Lisa Yuko Espinosa, Alex Samadi, Yuko Hiramoto, CJ Okumura, Toshiaki Maruyama, bioRxiv 2023.01.25.525589; doi: https://doi.org/10.1101/2023.01.25.525589
Melissa García-Vega, Edgar A. Melgoza-González, Sofía Hernández-Valenzuela, Harold Marcotte, Qiang Pan-Hammarström, Jesús Hernández et al., 19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern, iScience, Volume 26, ISSUE 4, 106562, April 21, 2023, https://doi.org/10.1016/j.isci.2023.106562
Fiaschi, L.; Biba, C.; Varasi, I.; Bartolini, N.; Paletti, C.; Giammarino, F.; Saladini, F.; Zazzi, M.; Vicenti, I. In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants. Viruses 2024, 16, 168. https://doi.org/10.3390/v16020168

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Bebtelovimab Biosimilar – Anti-SARS-CoV-2 Spike Protein mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Price and Availability

Size

Clear

GET A QUOTE NOW

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us

RBD Domain

PX-COV-P046 250€

View product

Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 180€

View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

Bebtelovimab Biosimilar – Anti-SARS-CoV-2 Spike Protein mAb – Research Grade

SDS-PAGE for Bebtelovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein mAb

REVIEW YOUR PRODUCT

RBD Domain

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

Contact us

Cart (0 Items)